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Supplementary information 
Supplementary figure 1. Reduction in blood neutrophil count on Day 3 of treatment period. Each 
point is shown as the arithmetic mean (± SD) neutrophil percent change from naïve (pre-treatment) 
baseline versus time by treatment, on linear scale. 
Supplementary figure 2. Images of neutrophils from representative subjects treated with either 
placebo or AZD5069. 
Neutrophil phagocytic function was visualised using a multispectral imaging flow cytometry 
instrument (Imagestream-X, Amnis). Images taken at 0oC are negative controls; phagocytosis was 
triggered by cell incubation at 37oC. Individual neutrophils are visualised in bright field (BF), green 
fluorescence (E. coli FITC) that shows FITC-labelled E. coli engulfed within the cell. After exposure 
to propidium iodide (PI), which stains the cell nucleus, the figure shows typical segmented nuclei and 
a combination/superimposition of BF/E. coli FITC images.  
The Phagotest assay used in this study includes the fluorescence quenching step, which neutralises 
FITC fluorescence in E. coli that are not protected by being inside the neutrophils. Thus, on the 
placebo 37oC phagocytosis BF/E. coli FTC image, bacteria attached to the surface of the neutrophil 
are visible but lack green fluorescence label. 
 
  
Supplementary figure 3. Serum levels of high sensitivity C-reactive protein (hsCRP) remained low 











Supplementary table 2. Circulating neutrophil counts over time in human volunteers 
 
 
Supplementary table 3. Human volunteer neutrophil functional assays at the indicated timepoints. 
 
